Both in Pharmaceuticals
PDS Biotechnology vs Rallybio
Over the past year PDSB returned −1.9% and RLYB returned +271.0%; their daily moves had a correlation of 0.07.
PDSB −1.9% RLYB +271.0%Growth of $1, one year, split-adjusted
| Metric | PDSB | RLYB |
|---|---|---|
| Price | $0.9605 | $16.38 |
| Market cap | $69.6M | $87.0M |
| Today | +4.80% | +0.18% |
| 1 month | +14.1% | −3.2% |
| 6 months | −28.3% | +97.6% |
| Year to date | +24.8% | +198.4% |
| 1 year | +3.7% | +282.6% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 1.9× |
| Price / sales | — | 134.7× |
| Net cash | $1.2M | $92.8M |
| Dividend yield | — | — |
| Volatility (60d) | 306.8% | 21.3% |
| Short % of float | 5.3% | 1.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).